Midazolam oral spray - SUDA

Drug Profile

Midazolam oral spray - SUDA

Alternative Names: NVD-301; SUDA-003

Latest Information Update: 22 Aug 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator NovaDel Pharma
  • Developer SUDA
  • Class Benzodiazepines; Hypnosedatives; Sleep disorder therapies; Small molecules
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Anxiety disorders

Most Recent Events

  • 13 Aug 2013 SUDA Ltd acquires NovaDel Pharma's assets
  • 16 Apr 2013 Preclinical development is ongoing
  • 31 Mar 2010 Preclinical trials in Anxiety disorders in USA (Transmucosal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top